Malabaricone C inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through induction of heme oxygenase-1

Journal of Cellular Biochemistry

Volumn 113, Issue 9, 2012, Pages 2866-2876

  Lee, Suhyun ^a   Seo, Juhee ^a   Ryoo, Sungwoo ^a   Cuong, To Dao ^b   Min, Byung Sun ^b   Lee, Jeong Hyung ^a  

^a Kangwon National University   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

heme oxygenase 1; Malabaricone C; migration; proliferation; vascular smooth muscle cell

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOHEXIMIDE; DACTINOMYCIN; HEME OXYGENASE 1; HERBACEOUS AGENT; MALABARICONE C; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; MALE; NONHUMAN; NUTMEG; PLANT SEED; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HEME OXYGENASE-1; MALE; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RESORCINOLS;

MYRISTICA FRAGRANS; RATTUS;

EID: 84863667959     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24161     Document Type: Article

References (51)

1. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL,. 1999. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274: 26071-26078.
2. Banerjee D, Bauri AK, Guha RK, Bandyopadhyay SK, Chattopadhyay S,. 2008. Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. Eur J Pharmacol 578: 300-312.
3. Brunt KR, Fenrich KK, Kiani G, Tse MY, Pang SC, Ward CA, Melo LG,. 2006. Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol 26: 2027-2034.
4. Chen JS, Huang PH, Wang CH, Lin FY, Tsai HY, Wu TC, Lin SJ, Chen JW,. 2011. Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract. Atherosclerosis 214: 301-309.
5. Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, Duckers HJ,. 2009. Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119: 3017-3027.
6. Cho HY, Reddy SP, Kleeberger SR,. 2006. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal 8: 76-87.
7. Cuong TD, Hung TM, Na M, Ha do T, Kim JC, Lee D, Ryoo S, Lee JH, Choi JS, Min BS,. 2011. Inhibitory effect on NO production of phenolic compounds from Myristica fragrans. Bioorg Med Chem Lett 21: 6884-6887.
8. Durante W,. 2010. Targeting heme oxygenase-1 in vascular disease. Curr Drug Targets 11: 1504-1516.
9. Feng J, Zhang P, Chen X, He G,. 2011. PI3K and ERK/Nrf2 pathways are involved in oleanolic acid-induced heme oxygenase-1 expression in rat vascular smooth muscle cells. J Cell Biochem 112: 1524-1531.
10. Goncharova EA, Ammit AJ, Irani C, Carroll RG, Eszterhas AJ, Panettieri RA, Krymskaya VP,. 2002. PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283: L354-363.
11. Guan J, Wu X, Arons E, Christou H,. 2008. The p38 mitogen-activated protein kinase pathway is involved in the regulation of heme oxygenase-1 by acidic extracellular pH in aortic smooth muscle cells. J Cell Biochem 105: 1298-1306.
12. Hosoi S, Kiuchi F, Nakamura N, Imasho M, Ali MA, Sasaki Y, Tanaka E, Tsumamoto Y, Kondo K, Tsuda Y,. 1999. Synthesis and nematocidal activity of diarylnonanoids related to malabaricones. Chem Pharm Bull (Tokyo) 47: 37-43.
13. Hwangbo C, Kim J, Lee JJ, Lee JH,. 2010. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Cα and the PDZ adapter protein mda-9/syntenin. Cancer Res. 70: 1645-1655.
14. Idriss NK, Blann AD, Lip GY,. 2008. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 52: 971-978.
15. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M,. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86.
16. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, Chau LY,. 2001. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519-1525.
17. Kang MI, Kobayashi A, Wakabayashi N, Kim SG, Yamamoto M,. 2004. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci USA 101: 2046-2051.
18. Kher N, Marsh JD,. 2004. Pathobiology of atherosclerosis-a brief review. Semin Thromb Hemost 30: 665-672.
19. Kim JY, Cho HJ, Sir JJ, Kim BK, Hur J, Youn SW, Yang HM, Jun SI, Park KW, Hwang SJ, Kwon YW, Lee HY, Kang HJ, Oh BH, Park YB, Kim HS,. 2009. Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia. Cardiovasc Res 82: 550-560.
20. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, Dulak J,. 2008. Heme oxygenase-1 and the vascular bed: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 1767-1812.
21. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R,. 2007. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 115: 1051-1058.
22. Maines MD, Panahian N,. 2001. The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions? Adv Exp Med Biol 502: 249-272.
23. Makabe S, Takahashi Y, Watanabe H, Murakami M, Ohba T, Ito H,. 2010. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway. Atherosclerosis 213: 377-384.
24. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A,. 2004. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/AKT pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279: 8919-8929.
25. Morita T, Jinno K, Kawagishi H, Arimoto Y, Suganuma H, Inakuma T, Sugiyama K,. 2003. Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans) on lipopolysaccharide/D-galactosamine-induced liver injury. J Agric Food Chem 51: 1560-1565.
26. Morita T,. 2005. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 25: 1786-1795.
27. Morse D, Lin L, Choi AM, Ryter SW,. 2009. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med 47: 1-12.
28. Muto A, Fitzgerald TN, Pimiento JM, Maloney SP, Teso D, Paszkowiak JJ, Westvik TS, Kudo FA, Nishibe T, Dardik A,. 2007. Smooth muscle cell signal transduction: Implications of vascular biology for vascular surgeons. J Vasc Surg 45 (Suppl A): A15-24.
29. Nakao A, Murase N, Ho C, Toyokawa H, Billiar TR, Kanno S,. 2005. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 112: 587-591.
30. Nègre-Aminou P, van Vliet AK, van Erck M, van Thiel GC, van Leeuwen RE, Cohen LH,. 1997. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. Biochim Biophys Acta 1345: 259-268.
31. Olajide OA, Ajayi FF, Ekhelar AI, Awe SO, Makinde JM, Alada AR,. 1999. Biological effects of Myristica fragrans (nutmeg) extract. Phytother Res 13: 344-345.
32. Ollinger R, Yamashita K, Bilban M, Erat A, Kogler P, Thomas M, Csizmadia E, Usheva A, Margreiter R, Bach FH,. 2007. Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle 6: 39-43.
33. Orabi KY, Mossa JS, el-Feraly FS,. 1991. Isolation and characterization of two antimicrobial agents from mace (Myristica fragrans). J Nat Prod 54: 856-859.
34. Owens GK, Kumar MS, Wamhoff BR,. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
35. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S,. 2010. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80: 1895-1903.
36. Patro BS, Bauri AK, Mishra S, Chattopadhyay S,. 2005. Antioxidant activity of Myristica malabarica extracts and their constituents. J Agric Food Chem 53: 6912-6918.
37. Patro BS, Tyagi M, Saha J, Chattopadhyay S,. 2010. Comparative nuclease and anti-cancer properties of the naturally occurring malabaricones. Bioorg Med Chem 18: 7043-7051.
38. Park ES, Lim Y, Hong JT, Yoo HS, Lee CK, Pyo MY, Yun YP,. 2010. Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway. Vascul Pharmacol 53: 61-67.
39. Peterson SJ, Frishman WH, Abraham NG,. 2009. Targeting heme oxygenase: Therapeutic implications for diseases of the cardiovascular system. Cardiol Rev 17: 99-111.
40. Raines EW,. 2004. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15: 237-254.
41. Rodriguez AI, Gangopadhyay A, Kelley EE, Pagano PJ, Zuckerbraun BS, Bauer PM,. 2010. HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1. Arterioscler Thromb Vasc Biol 30: 98-104.
42. Roos TU, Heiss EH, Schwaiberger AV, Schachner D, Sroka IM, Oberan T, Vollmar AM, Dirsch VM,. 2011. Caffeic acid phenethyl ester inhibits PDGF-induced proliferation of vascular smooth muscle cells via activation of p38 MAPK, HIF-1α, and heme oxygenase-1. J Nat Prod 74: 352-356.
43. Ross R,. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801-809.
44. Ryter SW, Morse D, Choi AM,. 2007. Carbon monoxide and bilirubin: Potential therapies for pulmonary/vascular injury and disease. Am J Respir Cell Mol Biol 36: 175-182.
45. Schwartz SM,. 1997. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 100: S87-S89.
46. Seidel P, Goulet S, Hostettler K, Tamm M, Roth M,. 2010. DMF inhibits PDGF-BB induced airway smooth muscle cell proliferation through induction of heme-oxygenase-1. Respir Res 11: 145.
47. Skaletz-Rorowski A, Lutchman M, Kureishi Y, Lefer DJ, Faust JR, Walsh K,. 2003. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res 57: 253-264.
48. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY,. 1998. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720.
49. Wang Y, Lindstedt KA, Kovanen PT,. 1995. Mast cell granule remnants carry LDL into smooth muscle cells of synthetic phenotype and induce their conversion into foam cells. Arterioscler Thromb Vasc Biol 15: 801-810.
50. Yellaturu CR, Bhanoori M, Neeli I, Rao GN,. 2002. N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem 277: 40148-40155.
51. Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, Perrella MA,. 2003. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17: 1759-1761.